Search results for: Adrian Towse
Filter search results
Critique of Research Proposing to Lower NICE’s Cost-per-QALY Threshold to £12,936
2 December 2013
…If these assumptions do not hold, then Claxton et al overestimate the success of PCTs in improving health and consequently underestimate the NICE threshold. [1] Download Barnsley, P., Towse, A., Schaffer,…
Biosimilars and HTA: Results of a Roundtable Discussion
9 April 2014
…J. & Towse, A., 2014. What is the role of HTA for biosimilars? Briefing, 54, London: Office of Health Economics. For other OHE publications on biosimilars, click here. For additional…
The Expanding Value Footprint of Oncology Treatments
13 May 2014
…full report is available for download from the OHE Consulting website. Download: Rejón-Parrilla, J.C., Hernández-Villafuerte, K., Shah, K., Mestre-Ferrandiz, J., Garrison, L. and Towse, A., 2014. The expanding value footprint…
Care at the End of Life: An Economic Perspective
6 April 2016
…European Journal of Health Economics, 15(4), pp.389-399. [available here] Garau, M., Shah, K.K., Mason, A., Wang, Q., Towse, A. and Drummond, M., 2011. Using QALYs in cancer: A review of…
OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?
17 May 2016
…work: Garau, M., Shah, K.K., Sharma, P. and Towse, A., 2016. Is the Link Between Health and Wealth Considered in Decision Making? Results from a Qualitative Study. International Journal of…
Contract Theory: Nobel Offerings to Health Economics
11 October 2016
…performance of the product in a defined patient population over a defined time period, so that reimbursement is based on the health and cost outcomes achieved (Garrison, Towse et al.,…
Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico
4 January 2017
…process. Download the full reports here: Policy Options for Formulary Development in Middle-income Countries Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study A related publication is: Towse,…
A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List
19 May 2018
…have prices three times above the estimated price. The OHE Report is funded by the IFPMA and co-authored by Adrian Towse, Karla Hernandez-Villafuerte and Brendan Shaw. Read the…
NICE Recommendation Highlights Role of Social Value Judgements
9 August 2018
…A review of the literature. Health Policy, 93(2-3), pp.77-84. DOI | RePEc Towse, A. and Garau, M., 2018. Appraising ultra-orphan drugs: is cost-per QALY appropriate? A review of the evidence….